• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在辅助细胞中部分重建具有复制能力的逆转录病毒,载体与辅助细胞基因组之间存在部分重叠。

Partial reconstitution of a replication-competent retrovirus in helper cells with partial overlaps between vector and helper cell genomes.

作者信息

Martinez I, Dornburg R

机构信息

Graduate Program in Microbiology and Molecular Genetics, Rutgers University, New Brunswick, NJ 08903, USA.

出版信息

Hum Gene Ther. 1996 Apr 10;7(6):705-12. doi: 10.1089/hum.1996.7.6-705.

DOI:10.1089/hum.1996.7.6-705
PMID:8919592
Abstract

Contamination of retroviral vector preparations with replication-competent retroviruses is a major safety concern in human gene therapy. These can arise by recombination between retroviral vectors and packaging cell sequences. Recently, we constructed new packaging lines, derived from spleen necrosis virus (SNV) that do not contain overlapping regions of homology between these two components (DSH134G and DSH29B cells). These cell lines were tested for the presence of recombination products and replication-competent viruses in comparison to a similar packaging line (DSN) that contains a partial overlap between vector and viral protein coding regions. No recombination products were detected in DSH cells. However, we found that recombination had occurred in DSN cells, partially reconstituting a provirus-like structure that was capable of being spread, although inefficiently, through an infected cell culture. Our data indicate that even small regions of sequence homology eventually allow homologous recombination between vector and helper cell genomes.

摘要

逆转录病毒载体制剂被具有复制能力的逆转录病毒污染是人类基因治疗中的一个主要安全问题。这些具有复制能力的逆转录病毒可通过逆转录病毒载体与包装细胞序列之间的重组产生。最近,我们构建了源自脾坏死病毒(SNV)的新包装细胞系,这两个组件(DSH134G和DSH29B细胞)之间不包含同源重叠区域。与包含载体和病毒蛋白编码区域之间部分重叠的类似包装细胞系(DSN)相比,对这些细胞系进行了重组产物和具有复制能力的病毒的检测。在DSH细胞中未检测到重组产物。然而,我们发现DSN细胞中发生了重组,部分重构了一种类似前病毒的结构,这种结构能够在受感染的细胞培养物中传播,尽管效率不高。我们的数据表明,即使是很小的序列同源区域最终也会允许载体与辅助细胞基因组之间发生同源重组。

相似文献

1
Partial reconstitution of a replication-competent retrovirus in helper cells with partial overlaps between vector and helper cell genomes.在辅助细胞中部分重建具有复制能力的逆转录病毒,载体与辅助细胞基因组之间存在部分重叠。
Hum Gene Ther. 1996 Apr 10;7(6):705-12. doi: 10.1089/hum.1996.7.6-705.
2
Spliced spleen necrosis virus vector RNA is not encapsidated: implications for retroviral replication and vector design.剪接的脾坏死病毒载体RNA未被衣壳化:对逆转录病毒复制和载体设计的启示。
Mol Ther. 2004 Apr;9(4):557-65. doi: 10.1016/j.ymthe.2004.01.009.
3
A single short stretch of homology between adenoviral vector and packaging cell line can give rise to cytopathic effect-inducing, helper-dependent E1-positive particles.腺病毒载体与包装细胞系之间一段单一的短同源序列可产生诱导细胞病变效应的、依赖辅助病毒的E1阳性颗粒。
Hum Gene Ther. 2002 May 20;13(8):909-20. doi: 10.1089/10430340252939023.
4
Cross-packaging of human immunodeficiency virus type 1 vector RNA by spleen necrosis virus proteins: construction of a new generation of spleen necrosis virus-derived retroviral vectors.人免疫缺陷病毒1型载体RNA被脾坏死病毒蛋白进行交叉包装:新一代源自脾坏死病毒的逆转录病毒载体的构建
J Virol. 2004 Jun;78(12):6480-8. doi: 10.1128/JVI.78.12.6480-6488.2004.
5
Construction of a retroviral vector production system with the minimum possibility of a homologous recombination.构建同源重组可能性最小的逆转录病毒载体生产系统。
Gene Ther. 2003 Apr;10(8):706-11. doi: 10.1038/sj.gt.3301892.
6
A novel MVMp-based vector system specifically designed to reduce the risk of replication-competent virus generation by homologous recombination.一种专门设计的基于微小病毒MVMp的载体系统,旨在降低通过同源重组产生具有复制能力病毒的风险。
Gene Ther. 2001 Jun;8(12):921-9. doi: 10.1038/sj.gt.3301477.
7
A replication-competent retrovirus arising from a split-function packaging cell line was generated by recombination events between the vector, one of the packaging constructs, and endogenous retroviral sequences.一种源自分裂功能包装细胞系的具有复制能力的逆转录病毒,是由载体、其中一个包装构建体与内源性逆转录病毒序列之间的重组事件产生的。
J Virol. 1998 Apr;72(4):2663-70. doi: 10.1128/JVI.72.4.2663-2670.1998.
8
Characterization of a replication-competent retrovirus resulting from recombination of packaging and vector sequences.由包装序列和载体序列重组产生的具有复制能力的逆转录病毒的特性分析。
Hum Gene Ther. 1994 May;5(5):567-75. doi: 10.1089/hum.1994.5.5-567.
9
Use of helper cells with two host ranges to generate high-titer retroviral vectors.使用具有两种宿主范围的辅助细胞来产生高滴度逆转录病毒载体。
Virology. 1993 Mar;193(1):385-95. doi: 10.1006/viro.1993.1135.
10
Bovine leukaemia virus packaging cell line for retrovirus-mediated gene transfer.用于逆转录病毒介导基因转移的牛白血病病毒包装细胞系。
J Gen Virol. 1989 Aug;70 ( Pt 8):1987-93. doi: 10.1099/0022-1317-70-8-1987.

引用本文的文献

1
Retroviral Vector Biosafety: Lessons from Sheep.逆转录病毒载体生物安全性:来自绵羊的经验教训。
J Biomed Biotechnol. 2003;2003(1):9-12. doi: 10.1155/S1110724303209128.
2
Two-helper RNA system for production of recombinant Semliki forest virus particles.用于生产重组塞姆利基森林病毒颗粒的双辅助RNA系统。
J Virol. 1999 Feb;73(2):1092-8. doi: 10.1128/JVI.73.2.1092-1098.1999.
3
Cell-type-specific gene transfer into human cells with retroviral vectors that display single-chain antibodies.利用展示单链抗体的逆转录病毒载体将细胞类型特异性基因导入人细胞。
J Virol. 1998 Dec;72(12):10148-56. doi: 10.1128/JVI.72.12.10148-10156.1998.
4
A replication-competent retrovirus arising from a split-function packaging cell line was generated by recombination events between the vector, one of the packaging constructs, and endogenous retroviral sequences.一种源自分裂功能包装细胞系的具有复制能力的逆转录病毒,是由载体、其中一个包装构建体与内源性逆转录病毒序列之间的重组事件产生的。
J Virol. 1998 Apr;72(4):2663-70. doi: 10.1128/JVI.72.4.2663-2670.1998.
5
Psi- vectors: murine leukemia virus-based self-inactivating and self-activating retroviral vectors.ψ-载体:基于小鼠白血病病毒的自失活和自激活逆转录病毒载体。
J Virol. 1997 Aug;71(8):6218-24. doi: 10.1128/JVI.71.8.6218-6224.1997.
6
Toward highly efficient cell-type-specific gene transfer with retroviral vectors displaying single-chain antibodies.利用展示单链抗体的逆转录病毒载体实现高效细胞类型特异性基因转移。
J Virol. 1997 Jan;71(1):720-5. doi: 10.1128/JVI.71.1.720-725.1997.